Bixiye
P63-16 Drug Related Prior Authorization Criteria Changes for Ampyra, H.P. Acthar Gel, Transmucosal Fentanyl, Growth Hormone, and Oral Pulmonary Arterial Hypertension Agents
Taariikhda uu dhaqangalayo Barnaamijka: Des 20, 2016
Dukumentiyadda & Foomamka Natiijooyinka
Soo bandhiga 2841 - 2850 ee natiijooyinka 3607
Bixiye
P31-17 New Drug-Related Prior Authorization (PA) with Quantity Limit (QL) Criteria: Thrombopoietin Receptor Agents
Taariikhda wax ku ool ah ee barnaamijka: Jun 05, 2017
Bixiye
P57-17 Addition of Drugs to the Self-Administered Oncology Prior Authorization with Quantity Limit Program
Taariikhda uu dhaqangalayo barnaamijka: Okt 24, 2017
Bixiye
P39-17 Concurrent Review for Inpatient Hospital Services at Select Facilities
Taariikhda dhaqangalka Barnaamijka: Jul 11, 2017
Bixiye
P62-16 EY Modifier for Platinum Blue Subscribers
Taariikhda uu dhaqangalayo Barnaamijka: Des 13, 2016
Bixiye
P32-16 New Drug-Related Prior Authorization Criteria with Quantity Limit for Kuvan
Taariikhda dhaqangalka Barnaamijka: Jul 27, 2016
Bixiye
P42-16 Change in Medical Policy and Commercial Benefit Coverage of Cologuard Colorectal Cancer Screening Test
Taariikhda barnaamijka Dhaqangalayso Agosto 08, 2016
Bixiye
P1-17 Prior Authorization Requirement for Gender Dysphoria
Taariikhda uu dhaqangalayo Barnaamijka: Jan 18, 2017
Bixiye
P44-16 Addition of a Drug (Viekira XR) to the Hepatitis C Second Generation Prior Authorization with Quantity Limit Program
Taariikhda uu Dhaqangalayo Barnaamijka: Sep 01, 2016
Bixiye
P47-17 Change to the Requirement to Submit National Drug Codes
Taariikhda barnaamijka Dhaqangalayso Agosto 23, 2017